References
Rota PA, Moss WJ, Takeda M, de Swart RL, Thompson KM, Goodson JL. Measles. Nat Rev Dis Primers. 2016;14(2):16049.
Measles. [cited 2019 Oct 20]. https://www.who.int/news-room/fact-sheets/detail/measles.
Mina MJ, Metcalf CJE, de Swart RL, Osterhaus ADME, Grenfell BT. Long-term measles-induced immunomodulation increases overall childhood infectious disease mortality. Science. 2015;348(6235):694–9.
Mina MJ, Kula T, Leng Y, Li M, de Vries RD, Knip M, et al. Measles virus infection diminishes preexisting antibodies that offer protection from otherpathogens. Science. 2019;366(6465):599–606.
Moss WJ, Griffin DE. Global measles elimination. Nat Rev Microbiol. 2006;4:900–8.
Strebel PM, Henao-Restrepo A-M, Hoekstra E, Olivé J-M, Cochi SL. Global measles elimination efforts: the significance of measles elimination in the United States. J Infect Dis. 2004;189:S251–7.
Measles Elimination in the U.S. | CDC. 2019 [cited 2019 Oct 20]. https://www.cdc.gov/measles/elimination.html.
Metcalf CJE, Ferrari M, Graham AL, Grenfell BT. Understanding herd immunity. Trends Immunol. 2015;36:753–5.
Javelle E, Colson P, Parola P, Raoult D. Measles, the need for a paradigm shift. Eur J Epidemiol. 2019. https://doi.org/10.1007/s10654-019-00569-4.
Fatemi Nasab GS, Salimi V, Abbasi S, Adjami Nezhad Fard F, Mokhtari Azad T. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran. Pathog Dis. 2016;74(8):089.
Dascalu S. Measles epidemics in romania: lessons for public health and future policy. Front Public Health. 2019;25(7):98.
Ciceri G, Canuti M, Bianchi S, Gori M, Piralla A, Colzani D, et al. Genetic variability of the measles virus hemagglutinin gene in B3 genotype strains circulating in Northern Italy. Infect Genet Evol. 2019;28(75):103943.
Kurchatova A, Krumova S, Vladimirova N, Nikolaeva-Glomb L, Stoyanova A, Kantardjiev T, et al. Preliminary findings indicate nosocomial transmission and Roma population as most affected group in ongoing measles B3 genotype outbreak in Bulgaria, March to August 2017. Eurosurveillance. 2017;22:30611.
Lochlainn LN, Mandal S, de Sousa R, Paranthaman K, van Binnendijk R, Ramsay M, et al. A unique measles B3 cluster in the United Kingdom and the Netherlands linked to air travel and transit at a large international airport, February to April 2014. Eurosurveillance. 2016;21:30177.
Chiem AT. Infectious disease/CDC update. Measles Outbreak-California, December 2014–February 2015. Ann Emerg Med. 2015;66(1):82–3.
Brown KE, Rota PA, Goodson JL, Williams D, Abernathy E, Takeda M, et al. Genetic characterization of measles and rubella viruses detected through global measles and rubella elimination surveillance, 2016–2018. MMWR. 2019;68:587–91.
Harriman K. NVAC meeting [cited 2019 Oct 21]. https://www.hhs.gov/sites/default/files/nvpo/nvac/meetings/pastmeetings/2015/2014-2015_california_measles_outbreak.pdf.
Takashima Y, Schluter WW, Mariano KML, Diorditsa S, de Quiroz Castro M, Ou AC, et al. Progress toward measles elimination—Philippines, 1998–2014. MMWR. 2015;64(13):357–62.
World Health Organization. MeaNS—measles nucleotide surveillance. [cited 2019 Oct 19]. http://www.who-measles.org/Public/Web_Front/main.php.
Patel MK, Orenstein WA. Classification of global measles cases in 2013–17 as due to policy or vaccination failure: a retrospective review of global surveillance data. Lancet Glob Health. 2019;7:e313–20.
Ackley SF, Hacker JK, Enanoria WTA, Worden L, Blumberg S, Porco TC, et al. Genotype-specific measles transmissibility: a branching process analysis. Clin Infect Dis. 2018;66(8):1270–5.
Hahné SJM, Nic Lochlainn LM, van Burgel ND, Kerkhof J, Sane J, Yap KB, et al. Measles outbreak among previously immunized healthcare workers, the Netherlands, 2014. J Infect Dis. 2016;214(12):1980–6.
Gandon S, Mackinnon MJ, Nee S, Read AF. Imperfect vaccines and the evolution of pathogen virulence. Nature. 2001;414(6865):751–6.
Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10(433):eaao5945.
Kanjilal S, Mina MJ. Passive immunity for the treatment of influenza: quality not quantity. Lancet Respir Med. 2019;7:922–3.
Xu GJ, Kula T, Xu Q, Li MZ, Vernon SD, Ndung’u T, et al. Comprehensive serological profiling of human populations using a synthetic human virome. Science. 2015;348(6239):aaa0698.
Funding
This work was funded by the National Institutes of Health (DP5-OD028145 to MJM and a Fogarty International Center Grant to BTG).
Author information
Authors and Affiliations
Contributions
All authors contributing equally to this work.
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yang, L., Grenfell, B.T. & Mina, M.J. Measles vaccine immune escape: Should we be concerned?. Eur J Epidemiol 34, 893–896 (2019). https://doi.org/10.1007/s10654-019-00574-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10654-019-00574-7